Kiyohiro Ando

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Cells

Cancer science

Journal of oncology

International journal of molecular sciences

Saitama Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Saitama Cancer Center Jul 01 2020

Japan

Deputy Department Director :: Research Institute for Clinical Oncology

Publications

Kiyohiro Ando, Akira Nakagawara
The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN. Cells 12 (4) (2023)
Kiyohiro Ando, Yusuke Suenaga, Takehiko Kamijo
DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN -Amplified Neuroblastoma IMR32 Cells. International journal of molecular sciences 24 (10) (2023)
Kiyohiro Ando, Akira Nakagawara
The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN. Cells 12 (4) (2023)
Kiyohiro Ando, Akira Nakagawara
The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN. Cells 12 (4) (2023)
Yoshitaka Shinno, Hisanori Takenobu, Ryuichi P Sugino, Yuki Endo, Ryu Okada, Masayuki Haruta, Shunpei Satoh, Kyosuke Mukae, Dilibaerguli Shaliman, Tomoko Wada, Jesmin Akter, Kiyohiro Ando, Atsuko Nakazawa, Hideo Yoshida, Miki Ohira, Tomoro Hishiki, Takehiko Kamijo
Polycomb EZH1 regulates cell cycle/5-fluorouracil sensitivity of neuroblastoma cells in concert with MYCN. Cancer science (2022)
Kiyohiro Ando, Akira Nakagawara
Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy? Biomolecules 11 (5) (2021)
Kiyohiro Ando, Miki Ohira, Ichiro Takada, Verna Cázares-Ordoñez, Yusuke Suenaga, Hiroki Nagase, Shinichi Kobayashi, Tsugumichi Koshinaga, Takehiko Kamijo, Makoto Makishima, Satoshi Wada
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis. Cancer science (2021)
Kiyohiro Ando, Verna Cázares-Ordoñez, Makoto Makishima, Atsushi Yokoyama, Yusuke Suenaga, Hiroki Nagase, Shinichi Kobayashi, Takehiko Kamijo, Tsugumichi Koshinaga, Satoshi Wada
CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma. Journal of oncology 2020 (2020)

Kiyohiro Ando.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kiyohiro Ando